Clinical Trial Update: A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma [Phase 3]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 3 study evaluating trabectedin (YONDELIS) in patients with locally advanced or metastatic liposarcoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma

Drugs mentioned

• Yondelis (trabectedin)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Advanced or Metastatic Liposarcoma or Leiomyosarcoma | Phase 3 | Status: COMPLETED